Inclusion Criteria:  Participant is either male or female and 18 to 75 years of age inclusive, at the time of signing the informed consent Obese participants with body mass index (BMI) within the range of 30 to 45 kg/m^2 (inclusive) Hepatic fat fraction (HFF) measured by magnetic resonance imaging derived proton density fat fraction (MRI-PDFF) ≥10% Liver injury and fibrosis assessment based on vibration controlled transient elastography (VCTE) liver stiffness measurement (LSM) score between 7 and 9.9kPa inclusive and aspartate aminotransferase (AST) >20U/L.  Exclusion Criteria:  Documented clinical, laboratory or radiologic evidence of cirrhosis (compensated or decompensated) Triglycerides ≥ 500 mg/dL Change in body weight (more than 5% self-reported OR 5 kg self-reported change during the previous 3 months from Screening) History of type 1 diabetes, diabetic ketoacidosis, or positive glutamic acid decarboxylase (GAD) auto-antibodies (latent autoimmune diabetes in adults) Hemoglobin A1c > 9.5%.